About Invesco Dynamic Biotechnology & Genome ETF (PBE)

The Invesco Dynamic Biotechnology & Genome ETF (PBE) is an exchange-traded fund that aims to provide investors with exposure to the dynamic and rapidly evolving biotechnology and genome sector. PBE seeks to track the performance of the Dynamic Biotechnology & Genome Intellidex Index, which is composed of US-listed companies involved in the research, development, and commercialization of biotechnology and genome-related products and services. The ETF offers a diversified portfolio of companies spanning various subsectors within biotechnology and genome, including gene therapy, genomic sequencing, and molecular diagnostics to name a few.

PBE's investment strategy utilizes a rules-based methodology that evaluates companies based on a variety of factors, such as fundamental growth, stock valuation, investment timeliness, and risk. The ETF's portfolio is constructed to provide exposure to companies with strong growth potential and favorable investment characteristics, aiming to capture the potential upside of the biotechnology and genome sector.